AlphaVax
Biotechnology Research
2 Triangle Drive
126 employees
- Employees
- 126
AlphaVax Overview
- Headquarters
- 2 Triangle Drive
- Phone Number
- Available in AeroLeads
- Website
- alphavax.com
- Industry
- Biotechnology Research
- Employees
- 126
- Funding
- 12.6M
- Company Email
- Available in AeroLeads
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
About AlphaVax
The AlphaVax pipeline is targeting pandemic influenza and cytomegalovirus (CMV), as well as grant and collaborator-supported programs in HIV, prostate and breast cancer, and several biodefense vaccines. Clinical data from the first alphavaccine human trials have confirmed safety and immunological activity in man. These immune responses are characterized as robust and balanced antibody (B-cell) and cellular (T-cell) immune responses, confirming the promising data we have obtained in over a decade of intensive pre-clinical work with this vector platform.
AlphaVax Contact Details
Employees by Management Level
Manager
3 profiles
Executive
1 profile
Associate / junior
1 profile
Department Contact Coverage
| Department | Contacts | Phone | |
|---|---|---|---|
| General | 4 | 4 | 1 |
| Executive | 1 | 1 | 1 |
Compare Similar Companies to AlphaVax
Novo Nordisk
Pharmaceutical Manufacturing
AngioDynamics
Medical Equipment Manufacturing
Aktis Oncology
Biotechnology Research
GlobeImmune, Inc.
Biotechnology Research
ALGENTECH SAS
Research
XOventure Life Science Experts
Biotechnology
Genomatix AG
Biotechnology Research
Achelios Therapeutics
Biotechnology Research
CYTODEL Inc
Biotechnology Research
Aerial BioPharma LLC
Pharmaceutical Manufacturing